The Virus Counter® Plus platform utilizes highly specific Virotag® antibody-based reagents for the rapid, direct, and precise quantification of virus particles. These reagents are designed to support key viral vector and vaccine applications, enabling customers to gain fast and reliable insights into their upstream and downstream bioprocesses. Currently, the Virotag® reagent portfolio supports the quantification of Lentiviruses, Baculovirus, and Influenza A and B viruses. The platform combines dedicated reagents, integrated software, and automated 96 well plate analysis to deliver streamlined workflows, high reproducibility, and rapid time to result for modern virus manufacturing environments.